Table 3.
Results of Multinomial Regression Analysis of Past, Baseline (n = 331), and One-year (n = 157) Comorbid Anxiety and Depression in Predicting Attenuated Psychotic Symptom Trajectories
| Past Comorbidity | Baseline Comorbidity | One-year Comorbidity | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Exp(B) | 95% CI | P | Exp(B) | 95% CI | P | Exp(B) | 95% CI | P | |
| Increasing vs. persistently low trajectory | |||||||||
| Ethnicity | .694 | .251–1.921 | .482 | .679 | .245–1.881 | .457 | 1.032 | .286–3.734 | .961 |
| Gender | .551 | .230–1.322 | .182 | .644 | .276–1.505 | .310 | .701 | .229–2.145 | .533 |
| Currently employed | 1.201 | .485–2.976 | .629 | 1.206 | .485–2.996 | .687 | 1.672 | .517–5.403 | .390 |
| GAF | 1.001 | .961–1.042 | .972 | 1.000 | .960–1.042 | .998 | .998 | .944-1.054 | .933 |
| Trauma | 1.028 | 1.000–1.057 | .047 | 1.024 | .997–1.053 | .087 | 1.017 | .982–1.053 | .345 |
| Negative symptoms | .988 | .961–1.015 | .375 | .990 | .962–1.018 | .466 | .971 | .953–1.009 | .128 |
| Cognitive symptoms | 1.029 | .956–1.107 | .453 | 1.024 | .951–1.102 | .527 | 1.004 | .910–1.108 | .932 |
| Motor symptoms | 1.034 | .990–1.080 | .134 | 1.029 | .986–1.073 | .189 | 1.023 | .966–1.084 | .433 |
| General symptoms | 1.012 | .985–1.041 | .390 | 1.015 | .988–1.043 | .281 | 1.037 | 1.000–1.076 | .047 |
| Anxiety | .443 | .179–1.094 | .077 | .414 | .156–1.094 | .075 | 1.187 | .361–3.898 | .778 |
| Depression | 3.149 | 1.298–7.642 | .011 | 1.093 | .429–2.783 | .852 | .508 | .097–2.665 | .423 |
| Increasing vs. decreasing trajectory | |||||||||
| Ethnicity | .387 | .128–1.176 | .094 | .383 | .126–1.166 | .091 | .671 | .145–3.113 | .611 |
| Gender | .793 | .297–2.121 | .645 | .944 | .362–2.459 | .906 | 1.926 | .455–8.149 | .373 |
| Currently employed | .849 | .308–2.343 | .752 | .855 | .309–2.366 | .762 | .751 | .180–3.143 | .695 |
| GAF | .983 | .939–1.028 | .450 | .983 | .939–1.028 | .454 | .969 | .908–1.034 | .347 |
| Trauma | 1.019 | .989–1.051 | .218 | 1.015 | .984–1.046 | .353 | 1.018 | .974–1.064 | .432 |
| Negative symptoms | 1.009 | .977–1.041 | .596 | 1.010 | .978–1.043 | .546 | .975 | .931–1.020 | .271 |
| Cognitive symptoms | 1.002 | .923–1.087 | .967 | .996 | .918–1.081 | .928 | 1.032 | .916–1.164 | .602 |
| Motor symptoms | .994 | .949–1.040 | .786 | .989 | .946–1.034 | .629 | 1.009 | .966–1.053 | .383 |
| General symptoms | .980 | .950–1.010 | .188 | .982 | .953–1.013 | .250 | .980 | .950–1.010 | .688 |
| Anxiety | .511 | .187–1.394 | .190 | .440 | .151–1.282 | .133 | 2.662 | .500–14.169 | .251 |
| Depression | 3.137 | 1.165–8.450 | .024 | 1.266 | .441–3.3640 | .661 | .489 | .069–3457 | .473 |
Note: Significant and trend-level associations are highlighted in bold.